S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE CAS: 161394-50-9

CAS NO: 161394-50-9
S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE
Chemical Name: (S)-5-ALLYL-2-OXABICYCLO[3.3.0]OCT-8-ENE
Molecular Formula: C10H14O
Formula Weight: 150.22
CAS No.: 161394-50-9
Description Review
Description

S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE is a synthetic organic compound with a bicyclic structure. It is primarily used in the production of pharmaceuticals and agrochemicals. The compound has been shown to have biologically active properties and may have potential applications in medicine.

Chemical Name:

The chemical name for S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE is (3aS,5S)-5-allyl-3a,4,5,5a-tetrahydro-2-oxabicyclo[3.3.0]oct-8-ene.

Molecular Formula:

The molecular formula of S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE is C10H14O.

Formula Weight:

The formula weight for S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE is 150.217 g/mol.

CAS No:

The CAS number for S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE is 161394-50-9.

Top Ten Keywords from Google and Synonyms:

  1. Organic compound - A molecule containing carbon atoms bonded to hydrogen atoms and other elements.
  2. Bicyclic structure - A compound with two fused ring structures in its molecular structure.
  3. Pharmaceuticals - Medications used for treating illnesses and diseases.
  4. Agrochemicals - Chemicals used in agriculture for pest control and crop growth.
  5. Biologically active - A substance that has an effect on living organisms.
  6. Synthetic - A compound made in a laboratory instead of being naturally occurring.
  7. Formula weight - The molecular mass of a compound relative to the mass of an atom of carbon-12.
  8. CAS number - The unique identifier assigned to a chemical substance by the Chemical Abstracts Service.
  9. Tetrahydro - The prefix used to indicate a cycloalkane with one hydrogen atom replaced by a functional group.
  10. Octene - An alkene with eight carbon atoms.

Health Benefits of S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE:

S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE has not been studied extensively for therapeutic use in humans, but it has been shown to have biologically active properties in animal models. As a result, it may have potential applications in medicine, but this will require further investigation.

Potential Effects:

S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE has not been extensively studied in humans, so its effects are not well understood. Animal studies have shown that it may have potential as an antifungal and antibacterial compound, but more research is needed to verify these findings.

Product Mechanism:

The mechanism of action of S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE is not well understood, and more research is needed to determine its effects and how they may be produced.

Safety:

S-5-ALLYL-2-OXABICYCLO-3-3-0-OCT-8-ENE has not been extensively studied for safety in humans. As a result, its safety profile is not well established

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code